Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association of Serum Neurofilament Light Chain Levels at Disease Onset With Disability Worsening in Patients With a First Demyelinating Multiple Sclerosis Event Not Treated With High-Efficacy Drugs.
Monreal E, Fernández-Velasco JI, García-Sánchez MI, Sainz de la Maza S, Llufriu S, Álvarez-Lafuente R, Casanova B, Comabella M, Ramió-Torrentà L, Martínez-Rodríguez JE, Brieva L, Saiz A, Eichau S, Cabrera-Maqueda JM, Villarrubia N, Espiño M, Pérez-Miralles F, Montalbán X, Tintoré M, Quiroga-Varela A, Domínguez-Mozo MI, Rodríguez-Jorge F, Chico-García JL, Lourido D, Álvarez-Cermeño JC, Masjuan J, Costa-Frossard L, Villar LM. Monreal E, et al. Among authors: quiroga varela a. JAMA Neurol. 2023 Apr 1;80(4):397-403. doi: 10.1001/jamaneurol.2023.0010. JAMA Neurol. 2023. PMID: 36848127 Free PMC article.
Oligoclonal IgM bands are a promising biomarker for long-term cognitive outcomes in multiple sclerosis.
Coll-Martinez C, Quintana E, Buxó M, Salavedra-Pont J, Gasull-Vicens L, Quiroga-Varela A, Costa-Frossard L, Villar LM, Fernández-Díaz E, Gracia J, Aladro Y, Méndez-Burgos A, Cerezo M, Ramió-Torrentà L, Gich J. Coll-Martinez C, et al. Mult Scler Relat Disord. 2022 Dec;68:104397. doi: 10.1016/j.msard.2022.104397. Epub 2022 Nov 4. Mult Scler Relat Disord. 2022. PMID: 36544326
miRNA Signature in CSF From Patients With Primary Progressive Multiple Sclerosis.
Muñoz-San Martín M, Gómez I, Quiroga-Varela A, Gonzalez-Del Río M, Robles Cedeño R, Álvarez G, Buxó M, Miguela A, Villar LM, Castillo-Villalba J, Casanova B, Quintana E, Ramió-Torrentà L. Muñoz-San Martín M, et al. Among authors: quiroga varela a. Neurol Neuroimmunol Neuroinflamm. 2022 Dec 9;10(1):e200069. doi: 10.1212/NXI.0000000000200069. Print 2023 Jan. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 36724195 Free PMC article.
Differences in metacognition between multiple sclerosis phenotypes: cognitive impairment and fatigue are key factors.
Coll-Martinez C, Salavedra-Pont J, Buxó M, Quintana E, Quiroga-Varela A, Robles-Cedeño R, Puig M, Álvarez-Bravo G, Ramió-Torrentà L, Gich J. Coll-Martinez C, et al. Among authors: quiroga varela a. Front Psychol. 2023 Aug 23;14:1163112. doi: 10.3389/fpsyg.2023.1163112. eCollection 2023. Front Psychol. 2023. PMID: 37680235 Free PMC article.
Complement Activation Profiles Predict Clinical Outcomes in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Villacieros-Álvarez J, Lunemann JD, Sepulveda M, Valls-Carbó A, Dinoto A, Fernández V, Vilaseca A, Castillo M, Arrambide G, Bollo L, Espejo C, Llufriu S, Blanco Y, Armangue T, Álvarez Bravo G, Quiroga-Varela A, Ramió Torrentà L, Cobo-Calvo A, Tintore M, Mariotto S, Montalban X, Comabella M. Villacieros-Álvarez J, et al. Among authors: quiroga varela a. Neurol Neuroimmunol Neuroinflamm. 2025 Jan;12(1):e200340. doi: 10.1212/NXI.0000000000200340. Epub 2024 Dec 11. Neurol Neuroimmunol Neuroinflamm. 2025. PMID: 39661937 Free PMC article.
Evaluating the complement C1q levels in serum and cerebrospinal fluid in multiple sclerosis patients: Could it serve as a valuable marker in clinical practice?
Tortosa-Carreres J, Cubas-Núñez L, Piqueras M, Castillo-Villalba J, Quintanilla-Bordàs C, Quiroga-Varela A, Villarrubia N, Monreal E, Álvarez G, Gasque-Rubio R, Forés-Toribio L, Carratalà-Boscà S, Lucas C, Sanz MT, Ramió-Torrentà L, Villar LM, Casanova B, Laiz B, Pérez-Miralles FC. Tortosa-Carreres J, et al. Among authors: quiroga varela a. J Neuroimmunol. 2024 Sep 15;394:578428. doi: 10.1016/j.jneuroim.2024.578428. Epub 2024 Aug 3. J Neuroimmunol. 2024. PMID: 39121816
Serum biomarkers at disease onset for personalized therapy in multiple sclerosis.
Monreal E, Fernández-Velasco JI, Álvarez-Lafuente R, Sainz de la Maza S, García-Sánchez MI, Llufriu S, Casanova B, Comabella M, Martínez-Yélamos S, Galimberti D, Ramió-Torrentà L, Martínez-Ginés ML, Aladro Y, Ayuso L, Martínez-Rodríguez JE, Brieva L, Villarrubia N, Eichau S, Zamora J, Rodero-Romero A, Espiño M, Blanco Y, Saiz A, Montalbán X, Tintoré M, Domínguez-Mozo MI, Cuello JP, Romero-Pinel L, Ghezzi L, Pilo de la Fuente B, Pérez-Miralles F, Quiroga-Varela A, Rubio L, Rodríguez-Jorge F, Chico-García JL, Sainz-Amo R, Masjuan J, Costa-Frossard L, Villar LM. Monreal E, et al. Among authors: quiroga varela a. Brain. 2024 Dec 3;147(12):4084-4093. doi: 10.1093/brain/awae260. Brain. 2024. PMID: 39101570
Predictive potential of serum and cerebrospinal fluid biomarkers for disease activity in treated multiple sclerosis patients.
Tortosa-Carreres J, Cubas-Núñez L, Quiroga-Varela A, Castillo-Villalba J, Ramió-Torrenta L, Piqueras M, Gasqué-Rubio R, Quintanilla-Bordas C, Sanz MT, Lucas C, Huertas-Pons JM, Miguela A, Casanova B, Laiz-Marro B, Pérez-Miralles FC. Tortosa-Carreres J, et al. Among authors: quiroga varela a. Mult Scler Relat Disord. 2024 Aug;88:105734. doi: 10.1016/j.msard.2024.105734. Epub 2024 Jun 17. Mult Scler Relat Disord. 2024. PMID: 38909525
Calcitriol Treatment Is Safe and Increases Frataxin Levels in Friedreich Ataxia Patients.
Alemany-Perna B, Tamarit J, Cabiscol E, Delaspre F, Miguela A, Huertas-Pons JM, Quiroga-Varela A, Merchan Ruiz M, López Domínguez D, Ramió I Torrentà L, Genís D, Ros J. Alemany-Perna B, et al. Among authors: quiroga varela a. Mov Disord. 2024 Jul;39(7):1099-1108. doi: 10.1002/mds.29808. Epub 2024 May 2. Mov Disord. 2024. PMID: 38696306
Improving the efficiency of free kappa light chains as diagnostic biomarker of Multiple Sclerosis by using a novel algorithm.
Tortosa-Carreres J, Quiroga-Varela A, Castillo-Villalba J, Piqueras-Rodríguez M, Ramió-Torrenta L, Cubas-Núñez L, Gasqué-Rubio R, Quintanilla-Bordas C, Huertas-Pons JM, Miguela A, Casanova B, Laiz-Marro B, Pérez-Miralles FC. Tortosa-Carreres J, et al. Among authors: quiroga varela a. Mult Scler Relat Disord. 2023 Nov;79:104997. doi: 10.1016/j.msard.2023.104997. Epub 2023 Sep 9. Mult Scler Relat Disord. 2023. PMID: 37714099
32 results